CorMedix (CRMD) Net Margin (2014 - 2026)
CorMedix (CRMD) reported Net Margin of 25.50% for Q2 2026, down 24.40 percentage points from 49.90% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Net Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CorMedix's Net Margin came in at 44.51%, up 2.40 percentage points year-over-year; for FY2025, it came in at 52.31%, up 93.55 percentage points from FY2024.
- Net Margin has a five-year change of +9260.01 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at -41.24% in FY2024, -45409.90% in FY2022 (-30635.19 pp) and -14774.70% in FY2021 (-5567.00 pp).
- Five-year quarterly Net Margin spans a low of -100538.67% in Q3 2022 and a high of 91671.03% in Q1 2022.
- Year over year, Net Margin gained in two of the last four quarters, with an average year-over-year change of +468.95 percentage points.
- The high point for year-over-year Net Margin in five years was Q1 2022 (a gain of 83513.41 percentage points); the low point was Q3 2022 (a drop of 123117.96 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | CorMedix | 609.51 Mn | -43.01 Mn | 77.13 Mn | 25.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.50% |
| Dec 31, 2025 | 9.61% |
| Sep 30, 2025 | 104.11% |
| Jun 30, 2025 | 49.90% |
| Mar 31, 2025 | 52.82% |
| Dec 31, 2024 | 43.14% |
| Sep 30, 2024 | -24.24% |
| Jun 30, 2024 | -1,755.51% |
| Dec 31, 2022 | -27,637.70% |
| Sep 30, 2022 | -100,538.67% |
| Jun 30, 2022 | 35,759.66% |
| Mar 31, 2022 | 91,671.03% |
| Dec 31, 2021 | -13,814.54% |
| Sep 30, 2021 | 22,579.29% |
| Jun 30, 2021 | 56,159.20% |
| Mar 31, 2021 | 8,157.62% |
| Dec 31, 2020 | -68,075.68% |
| Sep 30, 2020 | 7,095.25% |
| Jun 30, 2020 | 23,110.14% |
| Mar 31, 2020 | 7,562.05% |
API Access
CorMedix Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();